Bank of New Hampshire »

United Therapeutics Corporation shares owned by Bank of New Hampshire

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Bank of New Hampshire from 13F filings

Historical chart of Bank of New Hampshire investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Bank of New Hampshire consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Bank of New Hampshire

Quarter filed Position value Share count Share price at filing
2024-09-30 $13k 35 358.34
2024-06-30 $11k 35 318.54
2024-03-31 $8.0k 35 229.71
2023-12-31 $7.7k 35 219.89
2023-09-30 $7.9k 35 225.86
2023-06-30 $7.7k 35 220.74

More positions owned by Bank of New Hampshire

Apple (AAPL)
Microsoft Corporation (MSFT)
iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
SPDR Gold Trust Gold Shs (GLD)
Vanguard Mid Cap ETF Mid Cap Etf (VO)
Alphabet Inc CL A Cap Stk Cl A (GOOGL)
iShares Intermediate Govt/Credit ETF Intrm Gov Cr Etf (GVI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spdr S&p 500 Etf Tr Unit (SPY)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
TJX Companies (TJX)
UnitedHealth (UNH)
Stryker Corporation (SYK)

View all positions for Bank of New Hampshire

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
AQR Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Nuveen Asset Management

View all funds holding United Therapeutics Corporation